The Neurology Lounge

We have just embarked in an update blitz at Neurochecklists

And here are 75 recently updated checklists,

With the latest neurology literature – spanning 25 journals!

***

Allgrove syndrome  

Alzheimer’s disease (AD) protective factors

Arteriovenous malformations (AVM) clinical features

Ataxia telangiectasia (AT)

Cardiac cephalalgia  

Cerebral amyloid angiopathy (CAA) investigations

Cerebral aneurysm rupture risk

Cerebral palsy clinical features

Charcot Marie Tootth disease type 1a (CMT1A)

Congenital myasthenic syndromes (CMS) genetic classification

***

Cramps causes

Down’s syndrome neurological features

Dravet syndrome treatment

Duchenne muscular dystrophy (DMD) clinical features

Duchenne muscular dystrophy (DMD) neurological features

Ebola virus disease clinical features

EGPA management

Ehlers Danlos syndrome (EDS) neurological features

Essential tremor (ET) non-drug treatments

Facial onset sensory motor neuropathy (FOSMN) investigations

***

Guillain Barre syndrome (GBS) clinical features

Guillain Barre syndrome (GBS) complications

Huntington’s disease (HD) differential diagnosis

Hypothalamic hamartoma management

Idiopathic intracranial hypertension(IIH) medical treatment

Lennox-Gastaut syndrome (LGS) clinical features

LGI1 encephalitis management

Medication overuse headache (MOH) clinical features

Metronidazole encephalopathy

Migraine co-morbidities

***

Migraine risk factors

MOG antibody disease (MOGAD) treatment

Motor neurone disease (MND) prognostic features

Multiple sclerosis (MS) investigational treatments

Multiple sclerosis (MS) poor prognostic factors

Multiple sclerosis (MS) risk factors

Multiple system atrophy (MSA) clinical features

Myasthenia gravis (MG) treatment

Myotonic dystrophy systemic features

Neurofibromatosis type 1 (NF1) neurological features

***

Ocrelizumab

Parkinson’s disease (PD) differential diagnosis

Parkinson’s disease (PD) MAOB inhibitors

Parkinson’s disease (PD) ophthalmic features

Parkinson’s disease (PD) poor prognostic features

Parkinson’s disease (PD) systemic risk factors

Pompe disease enzyme replacement therapy (ERT)  

Post traumatic parkinsonism

Primary angiitis of the CNS (PACNS) clinical features

Progressive supranuclear palsy (PSP) investigations

***

Recurrent ischaemic stroke

Refractory status epilepticus treatment

REM sleep behaviour disorder (RBD) conversion to parkinsonism

Reversible cerebral vasoconstriction syndrome (RCVS) causes

Rimegepant

Seizure recurrence risk factors

Small fiber neuropathy treatment

Sports related concussion (SRC) management 

Spinal muscular atrophy (SMA) clinical features

Spinal muscular atrophy (SMA) genetics

***

Stroke medical risk factors

Stroke risk factors

Subarachnoid haemorrhage (SAH) complications

Subarachnoid haemorrhage (SAH) vasospasm

SUDEP risk factors

Systemic lupus erythematosus (SLE) clinical features

Tension type headache (TTH) features

Trigeminal neuralgia (TN) neurovascular causes 

Tuberous sclerosis (TS) treatment

Vagus nerve stimulation (VNS)

***

Vestibular paroxysmia differentials

Visual snow syndrome (VSS) management

Vogt-Koyanagi Harada disease differentials

Wilson’s disease investigations

Xeroderma pigmentosum

***